RCEL
insider transactionsAVITA Medical, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Cluster buy signal: Multiple insiders at the same company buying around the same time — often a stronger signal than a single buy. 2 different insiders made open-market purchases in the last 365 days, totalling $226.6K.
Net shares · 365d
+54.0K
54.0K buy · 0 sell
Net value · 365d
$226.6K
$226.6K in · $0 out
Sentiment · 365d
Net buying
100% buying · 0% selling
Open-market trades · 365d
13
54.0K buy · 0 sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
David D O'Toole KEY
CFO
$7.9K
2.0K sh · $3.97
Own +1%
-
Buy·P
Director
$20.9K
5.0K sh · $4.18
Own +5%
-
Buy·P
Director
$21.0K
5.0K sh · $4.20
Own +5%
-
Buy·P
Director
$20.8K
5.2K sh · $4.00
Own +5%
-
Buy·P
Director
$20.4K
5.0K sh · $4.09
Own +6%
-
Buy·P
Director
$20.5K
5.0K sh · $4.10
Own +6%
-
Buy·P
Director
$21.0K
5.0K sh · $4.21
Own +33%
-
Buy·P
Director
$20.9K
5.0K sh · $4.18
Own +50%
-
Buy·P
Director
$21.3K
5.0K sh · $4.26
Own +100%
-
Buy·P
Director
$21.7K
5.0K sh · $4.34
Own New
-
Grant·A
David D O'Toole KEY
CFO
$15.3K
5.0K sh · $3.05
Own +3%
-
Grant·A
Cary Guy Vance KEY
President and CEO
$15.3K
5.0K sh · $3.05
Own +14%
-
Buy·P
David D O'Toole KEY
CFO
$8.5K
2.0K sh · $4.26
Own +1%
-
Buy·P
David D O'Toole KEY
CFO
$8.5K
2.0K sh · $4.24
Own +1%
-
Buy·P
David D O'Toole KEY
CFO
$8.6K
1.8K sh · $4.78
Own +1%
-
Buy·P
David D O'Toole KEY
CFO
$12.4K
3.0K sh · $4.15
Own +2%
-
Grant·A
David D O'Toole KEY
CFO
$0
155.5K sh
Own New
-
Grant·A
David D O'Toole KEY
CFO
—
105.5K sh
Own +333%
-
Grant·A
Chief Legal Officer
$0
145.1K sh
Own New
-
Grant·A
Chief Legal Officer
—
98.4K sh
Own New
-
Grant·A
Director
$0
16.1K sh
Own New
-
Grant·A
Director
—
22.2K sh
Own +47%
-
Grant·A
Director
$0
16.1K sh
Own New
-
Grant·A
Director
—
22.2K sh
Own +37%
-
Grant·A
Director
$0
16.1K sh
Own New
-
Grant·A
Director
—
22.2K sh
Own +85%
-
Grant·A
Director
$0
16.1K sh
Own New
-
Grant·A
Director
—
22.2K sh
Own +26%
-
Grant·A
Director
$0
16.1K sh
Own New
-
Grant·A
Director
—
22.2K sh
Own +56%
-
Grant·A
Director
$0
16.1K sh
Own New
-
Grant·A
Director
—
22.2K sh
Own +44%
-
Grant·A
Director
$0
29.4K sh
Own New
-
Grant·A
Director
—
40.5K sh
Own +203%
-
Grant·A
Director
$0
19.1K sh
Own New
-
Grant·A
Director
—
26.2K sh
Own New
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 12, 2026 | David D O'Toole KEY | Grant A | 2.0K | $7.9K |
| Jun 9, 2026 | Joseph Fralin Woody | Buy P | 5.0K | $20.9K |
| Jun 9, 2026 | Joseph Fralin Woody | Buy P | 5.0K | $21.0K |
| Jun 9, 2026 | Joseph Fralin Woody | Buy P | 5.2K | $20.8K |
| Jun 3, 2026 | Joseph Fralin Woody | Buy P | 5.0K | $20.4K |
| Jun 3, 2026 | Joseph Fralin Woody | Buy P | 5.0K | $20.5K |
| Jun 2, 2026 | Joseph Fralin Woody | Buy P | 5.0K | $21.0K |
| Jun 2, 2026 | Joseph Fralin Woody | Buy P | 5.0K | $20.9K |
| Jun 1, 2026 | Joseph Fralin Woody | Buy P | 5.0K | $21.3K |
| Jun 1, 2026 | Joseph Fralin Woody | Buy P | 5.0K | $21.7K |
| May 29, 2026 | David D O'Toole KEY | Grant A | 5.0K | $15.3K |
| May 29, 2026 | Cary Guy Vance KEY | Grant A | 5.0K | $15.3K |
| May 20, 2026 | David D O'Toole KEY | Buy P | 2.0K | $8.5K |
| May 19, 2026 | David D O'Toole KEY | Buy P | 2.0K | $8.5K |
| Mar 11, 2026 | David D O'Toole KEY | Buy P | 1.8K | $8.6K |
| Feb 19, 2026 | David D O'Toole KEY | Buy P | 3.0K | $12.4K |
| Feb 18, 2026 | David D O'Toole KEY | Grant A | 155.5K | $0 |
| Feb 18, 2026 | David D O'Toole KEY | Grant A | 105.5K | — |
| Feb 18, 2026 | Nicole Kelsey | Grant A | 145.1K | $0 |
| Feb 18, 2026 | Nicole Kelsey | Grant A | 98.4K | — |
| Jan 20, 2026 | Suzanne Crowe | Grant A | 16.1K | $0 |
| Jan 20, 2026 | Suzanne Crowe | Grant A | 22.2K | — |
| Jan 20, 2026 | Joseph Fralin Woody | Grant A | 16.1K | $0 |
| Jan 20, 2026 | Joseph Fralin Woody | Grant A | 22.2K | — |
| Jan 20, 2026 | Michael E Tarnoff | Grant A | 16.1K | $0 |
| Jan 20, 2026 | Michael E Tarnoff | Grant A | 22.2K | — |
| Jan 20, 2026 | Robert Mcnamara | Grant A | 16.1K | $0 |
| Jan 20, 2026 | Robert Mcnamara | Grant A | 22.2K | — |
| Jan 20, 2026 | Jeremy Curnock Cook | Grant A | 16.1K | $0 |
| Jan 20, 2026 | Jeremy Curnock Cook | Grant A | 22.2K | — |
| Jan 20, 2026 | Jan Stern Reed | Grant A | 16.1K | $0 |
| Jan 20, 2026 | Jan Stern Reed | Grant A | 22.2K | — |
| Jan 5, 2026 | Joseph Fralin Woody | Grant A | 29.4K | $0 |
| Jan 5, 2026 | Joseph Fralin Woody | Grant A | 40.5K | — |
| Aug 6, 2025 | Michael E Tarnoff | Grant A | 19.1K | $0 |
| Aug 6, 2025 | Michael E Tarnoff | Grant A | 26.2K | — |
About RCEL insider trading
This page tracks insider transactions for AVITA Medical, Inc. (RCEL) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.